Cumberland Pharmaceuticals Inc (CPIX) — Net Asset Quality Index
Cumberland Pharmaceuticals Inc (CPIX) has a Net Asset Quality Index of 30.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $71.00 Million minus total liabilities of $49.69 Million yields net assets of $21.30 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Cumberland Pharmaceuticals Inc (CPIX) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cumberland Pharmaceuticals Inc Net Asset Quality Index Over Time (2005–2025)
This chart shows how Cumberland Pharmaceuticals Inc's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the index stands at 30.0%, representing net assets of $21.30 Million against total assets of $71.00 Million USD. See CPIX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Cumberland Pharmaceuticals Inc (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Cumberland Pharmaceuticals Inc from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Cumberland Pharmaceuticals Inc worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 31.9% | $24.54 Million | $76.82 Million | $52.28 Million | ▲ +2.1 pp |
| 2024 | 29.8% | $22.55 Million | $75.58 Million | $53.04 Million | ▼ -6.0 pp |
| 2023 | 35.8% | $29.26 Million | $81.78 Million | $52.52 Million | ▼ -2.9 pp |
| 2022 | 38.7% | $35.97 Million | $92.93 Million | $56.95 Million | ▼ -11.7 pp |
| 2021 | 50.4% | $42.60 Million | $84.46 Million | $41.86 Million | ▲ +1.8 pp |
| 2020 | 48.6% | $46.87 Million | $96.46 Million | $49.59 Million | ▼ -0.3 pp |
| 2019 | 48.9% | $51.09 Million | $104.55 Million | $53.46 Million | ▼ -0.4 pp |
| 2018 | 49.3% | $55.57 Million | $112.69 Million | $57.12 Million | ▼ -19.3 pp |
| 2017 | 68.6% | $63.92 Million | $93.23 Million | $29.31 Million | ▼ -9.7 pp |
| 2016 | 78.3% | $73.12 Million | $93.40 Million | $20.28 Million | ▼ -5.3 pp |
| 2015 | 83.6% | $76.82 Million | $91.92 Million | $15.10 Million | ▼ -1.1 pp |
| 2014 | 84.6% | $80.75 Million | $95.41 Million | $14.65 Million | ▼ -5.9 pp |
| 2013 | 90.5% | $79.29 Million | $87.61 Million | $8.32 Million | ▲ +3.7 pp |
| 2012 | 86.8% | $85.57 Million | $98.59 Million | $13.03 Million | ▲ +0.1 pp |
| 2011 | 86.7% | $82.84 Million | $95.52 Million | $12.68 Million | ▲ +2.3 pp |
| 2010 | 84.4% | $77.72 Million | $92.05 Million | $14.34 Million | ▲ +14.8 pp |
| 2009 | 69.6% | $72.22 Million | $103.72 Million | $31.50 Million | ▲ +13.2 pp |
| 2008 | 56.4% | $17.55 Million | $31.12 Million | $13.56 Million | ▼ -1.5 pp |
| 2007 | 57.9% | $16.75 Million | $28.92 Million | $12.17 Million | ▲ +15.9 pp |
| 2006 | 42.0% | $11.13 Million | $26.48 Million | $15.36 Million | ▼ -19.3 pp |
| 2005 | 61.3% | $6.23 Million | $10.17 Million | $3.94 Million | — |